FIELD: medicine, radiodiagnostics.
SUBSTANCE: invention can be used to predict the development of nephrogenic anemia in patients with chronic kidney disease. Magnetic resonance imaging of the spleen and left kidney or right kidney, in case of nephrectomy of the left kidney is conducted. The examination is carried out in the mode of marking the spins of protons by a magnetic field in water molecules of arterial blood (ASL-perfusion) of the spleen and kidney with a quantitative assessment of perfusion in the parenchyma of the spleen (ASLS) and kidney (ASLK). The coefficient of development of nephrogenic anemia is calculated according to the formulaΔ AN = ASLS/ASLK. IfΔ AN<1, the development of nephrogenic anemia in patients with chronic kidney disease is predicted. IfΔ AN≥1, the absence of the development of nephrogenic anemia is predicted.
EFFECT: method provides prediction of the development of nephrogenic anemia in chronic kidney disease due to ASL-perfusion indicators.
1 cl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIFFERENTIAL DIAGNOSIS OF ACUTE RENAL INJURY | 2023 |
|
RU2834285C1 |
METHOD FOR DETERMINING RISK OF DEVELOPING AND PROGRESSION OF CHRONIC KIDNEY DISEASE OF VARIABLE AETIOLOGY IN ADULTS | 2024 |
|
RU2826852C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF ANEMIA OF CHRONIC DISEASES, IRON DEFICIENCY ANEMIA AND COMBINED VERSION OF ANEMIA OF CHRONIC DISEASES AND IRON DEFICIENCY ANEMIA IN CHRONIC HEPATITIS AND CIRRHOSIS OF LIVER | 2023 |
|
RU2817212C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF SUBCLINICAL AND STAGES OF CLINICAL ACUTE KIDNEY INJURIES | 2023 |
|
RU2797880C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF THE PRESENCE OR ABSENCE OF SPLENOMEGALY AND HYPERSPLENISM SYNDROMES IN PATIENTS WITH HEPATITIS AND LIVER CIRRHOSE | 2022 |
|
RU2790367C1 |
METHOD FOR ASSESSING PROBABILITY OF DEVELOPING NEPHRITIS IN DIFFUSE LIVER DISEASES | 2022 |
|
RU2792321C1 |
METHOD FOR ASSESSING THE RISK OF PROGRESSION OF LIVER FIBROSIS IN VIRAL HEPATITIS | 2021 |
|
RU2774596C1 |
METHOD OF EARLY PREDICTION OF RENAL DYSFUNCTION DEVELOPMENT IN PATIENTS WITH DIFFUSED B-LARGE CELL LYMPHOMA AT THE STAGE OF INDUCTION IMMUNOPOLYCHEMOTHERAPY | 2022 |
|
RU2799126C1 |
METHOD FOR VERIFICATION OF SYMPTOMATIC AND MINIMAL HEPATIC ENCEPHALOPATHY IN CHRONIC HEPATITIS AND LIVER CIRRHOSIS | 2022 |
|
RU2792568C1 |
METHOD FOR PREDICTING THE OUTCOME OF CIRRHOSIS IN HEPATIC CANCER CIRRHOSIS | 2020 |
|
RU2741691C1 |
Authors
Dates
2023-08-03—Published
2023-06-07—Filed